Financial Performance - The company's operating revenue for Q1 2023 was RMB 21,628,521 thousand, representing a year-on-year increase of 5.31%[4] - The net profit attributable to shareholders was RMB 1,908,600 thousand, reflecting a growth of 5.70% compared to the same period last year[4] - Basic earnings per share for the quarter stood at RMB 1.174, marking a 5.70% increase from the previous year[5] - The net profit for Q1 2023 was approximately ¥1.97 billion, an increase from ¥1.89 billion in Q1 2022, representing a growth of about 4.6%[17] - The operating profit for Q1 2023 was ¥2.35 billion, compared to ¥2.26 billion in Q1 2022, showing an increase of approximately 4%[17] - The total comprehensive income for Q1 2023 was approximately ¥1.96 billion, compared to ¥1.89 billion in Q1 2022, representing an increase of about 3.7%[18] Cash Flow - The net cash flow from operating activities was negative at RMB (2,838,882) thousand, a significant decrease of 409.22% year-on-year[4][7] - The cash flow from operating activities showed a net outflow of approximately ¥2.84 billion, contrasting with a net inflow of ¥918.06 million in Q1 2022[20] - Net cash flow from investment activities was (¥638,055,604.71), worsening from (¥429,198,901.93) year-over-year[21] - Net cash flow from financing activities improved to ¥1,571,436,553.79, compared to ¥848,637,912.69 in the previous year, showing an increase of about 85%[21] Assets and Liabilities - Total assets at the end of the reporting period were RMB 73,658,300 thousand, down 1.35% from the end of the previous year[5] - Current assets totaled ¥55,437,164,388.07 as of March 31, 2023, a decrease of 2.2% from ¥57,064,311,513.29 at the end of 2022[12] - Non-current assets increased to ¥18,221,135,787.49 from ¥17,600,987,263.45, marking a growth of 3.5%[13] - Total liabilities decreased to ¥38,057,349,122.22 from ¥41,027,440,697.52, a reduction of 7.2%[14] Shareholder Information - The equity attributable to shareholders increased to RMB 33,967,845 thousand, a rise of 5.93% compared to the previous year[5] - The total number of ordinary shareholders at the end of the reporting period was 86,846[8] - The largest shareholder, Guangzhou Pharmaceutical Group Co., Ltd., holds 45.04% of the shares, totaling 732,305,103 shares[8] Expenses and Investments - Total operating costs for Q1 2023 were ¥19,332,774,093.08, up from ¥18,312,100,904.61 in Q1 2022, reflecting a year-over-year increase of 5.6%[15] - Research and development expenses decreased to ¥179.39 million from ¥238.88 million, reflecting a reduction of about 25%[17] - The company reported a tax expense of approximately ¥385.93 million, up from ¥372.24 million in the previous year, indicating an increase of about 3.5%[17] - The investment income for Q1 2023 was approximately ¥81.73 million, a substantial increase from ¥20.90 million in the same period last year, reflecting a growth of about 290%[17] Cash and Equivalents - The company's cash and cash equivalents were ¥20,245,924,699.78, down 10.0% from ¥22,499,552,770.75 in the previous year[12] - The ending balance of cash and cash equivalents stood at ¥18,900,995,214.13, down from ¥22,350,305,251.23 year-over-year[21] - The net increase in cash and cash equivalents was (¥1,903,703,798.51), a decline from an increase of ¥1,336,941,209.01 in the prior year[21] Other Financial Metrics - Non-recurring gains and losses totaled RMB 81,164 thousand for the quarter, with government subsidies contributing RMB 36,754 thousand[6] - The weighted average return on equity decreased by 0.25 percentage points to 5.78%[5] - Long-term borrowings increased significantly to ¥3,136,584,449.64 from ¥1,639,203,064.38, indicating a rise of 91.2%[14] - Total cash inflow from investment activities reached ¥284,035,293.15, compared to ¥74,603,372.98 in the previous year, marking an increase of approximately 280%[21] - Cash outflow from investment activities totaled ¥922,090,897.86, up from ¥503,802,274.91, representing an increase of about 83%[21] - Cash inflow from financing activities amounted to ¥6,768,424,606.31, compared to ¥4,745,085,207.77, reflecting a growth of around 42.6%[21] - Cash outflow from financing activities was ¥5,196,988,052.52, an increase from ¥3,896,447,295.08, indicating a rise of approximately 33.4%[21] Accounting Standards - The company did not implement new accounting standards or interpretations for the current fiscal year[21]
白云山(600332) - 2023 Q1 - 季度财报